Legal Representation
Attorney
Tracy-Gene G. Durkin
USPTO Deadlines
Next Deadline
1720 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-04-16)
Due Date
April 16, 2030
Grace Period Ends
October 16, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
41 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 25, 2024 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | Loading... |
| Apr 16, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Apr 16, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Mar 14, 2024 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Mar 13, 2024 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Mar 8, 2024 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Mar 8, 2024 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | Loading... |
| Feb 27, 2024 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Feb 26, 2024 | DRRR | I | DIVISIONAL REQUEST RECEIVED | Loading... |
| Feb 8, 2024 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Feb 8, 2024 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | Loading... |
| Feb 8, 2024 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Aug 11, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 9, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Aug 9, 2023 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Aug 9, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 11, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 9, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Feb 9, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Feb 9, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 9, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 14, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 14, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 25, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 10, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 26, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 6, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 6, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 6, 2022 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Nov 12, 2021 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Nov 12, 2021 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Nov 12, 2021 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Oct 13, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 12, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 12, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Apr 13, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Apr 13, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Apr 13, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Apr 12, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 6, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Nov 9, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for use in the treatment of cancer and tumors; pharmaceutical preparations for use in the treatment of oncological diseases, disorders, and conditions; pharmaceutical preparations for human use, namely, pharmaceutical antibodies; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of oncological diseases, disorders, and conditions; pharmaceutical preparations for the treatment of oncological diseases, disorders, and conditions; biological preparations for the treatment of oncological diseases, disorders, and conditions
First Use Anywhere:
May 3, 2021
First Use in Commerce:
May 3, 2021
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"